ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytes
ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytes
批准号:
8120280
负责人:
Theresa A Freeman
金额:
$11.59万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-01 至 2013-08-31
关键词:
Acute suppurative arthritis due to bacteriaAffectAgeAgingAnimalsAntioxidantsApoptosisBindingCardiac MyocytesCartilageCell CycleCell DeathCell physiologyCellsCessation of lifeChondrocytesDataEnzymesEpiphysial cartilageEquilibriumExposure toFunctional disorderGene ExpressionGenerationsGenesHumanHypertrophyHypoxiaInflammationInjuryMAP Kinase Kinase KinaseMAP3K5 geneMeasurementMediatingMolecularMusNerve DegenerationOsteoarthrosis DeformansOxidantsOxidative StressPathologyPlasmidsPlayProductionProteinsReactive Oxygen SpeciesRegulationResistanceRoleSepsisSignal TransductionSignaling ProteinSmall Interfering RNASystemic diseaseTechnologyTestingTherapeutic InterventionThioredoxinTissuesToxic Environmental Substancesarticular cartilagebHLH-PAS factor HLFbasecartilage cellcartilage developmentcatalaseglutaredoxinimprovedinsightnovelnovel strategiesoverexpressionprotein expressionpublic health relevancetranscription factor
中文摘要
描述(申请人提供):在软骨中,活性氧(ROS)信号在调节软骨细胞增殖、分化和成熟中起着重要作用。为了确保适当的细胞功能,活性氧是通过产生抗氧化剂来平衡的;因为不受调节的ROS会导致基因表达、转录因子信号传导和细胞周期的功能障碍。在衰老、全身性疾病、环境毒素暴露、损伤和炎症中,ROS的产生可以压倒抗氧化能力,引发异常信号,导致细胞死亡、基质降解和形成和永久软骨的病理损伤。凋亡信号调节激酶1 (Apoptosis signal- regulatory kinase 1, ASK1)是一种MAP激酶激酶,是一种与病理ROS信号有关的蛋白。在我们的初步数据中,我们发现Ask1存在于生长板和关节软骨细胞中。我们还发现缺氧诱导因子2 (HIF-2)是一种调控软骨细胞抗氧化表达的转录调节因子。综上所述,我们认为软骨细胞的氧化状态是由HIF-2的表达控制的;Ask1的激活是氧化应激的功能测量。我们将研究HIF-2控制的抗氧化剂表达与ROS激活Ask1之间的关系。通过操纵这两个分子的表达,我们将探索ROS在软骨细胞分化和停滞中的正常和病理作用。在Specific Aim 1中,我们将使用siRNA沉默Ask1基因表达,研究Ask1作为软骨细胞氧化应激指标的作用机制及其在ROS诱导的软骨病理中的作用。在特异性目的2中,我们将研究HIF-2的表达通过抗氧化调节来控制细胞氧化状态。通过控制HIF-2的表达,使用siRNA沉默HIF-2基因表达和缺氧独立质粒进行过表达,我们将确定细胞氧化状态、ROS介导的Ask1激活、软骨细胞分解代谢活性和存活。通过仔细分析软骨细胞氧化应激改变的信号机制,我们提出的研究将对理解氧化应激的分子机制产生巨大影响,并为开发新的治疗干预靶点提供重要信息。
英文摘要
DESCRIPTION (provided by applicant): In cartilage, reactive oxygen species (ROS) signaling plays significant role in regulating chondrocyte proliferation, differentiation and maturation. To assure proper cellular function ROS is balanced by production of antioxidants; as unregulated ROS can cause dysfunction in gene expression, transcription factor signaling, and cell cycle. In aging, systemic disease, environmental toxin exposure, injury and inflammation, ROS production can overwhelm the antioxidant capacity triggering aberrant signaling leading to cell death, matrix degradation and pathological damage in both forming and permanent cartilages. Apoptosis signal-regulating kinase 1 (ASK1) a MAP kinase kinase kinase, is a well characterized protein implicated in pathological ROS signaling. In our preliminary data, we show Ask1 is present in growth plate and articular chondrocytes. We also show that hypoxia inducible factor 2 (HIF-2) is a transcriptional regulator controlling antioxidant expression in chondrocytes. Taken together, we propose that in cartilage the oxidative status of the cell is controlled by expression of HIF-2; and activation of Ask1 is a functional measurement of oxidative stress. We will investigate the relationship between HIF-2 controlled expression of antioxidants and activation of Ask1 by ROS. By manipulating the expression of these two molecules we will explore the normal and pathological role of ROS in chondrocyte differentiation and stasis. In Specific Aim 1, using siRNA to silence Ask1 gene expression we will investigate the mechanism of action of Ask1 as an indicator of oxidative stress in chondrocytes and its role in ROS induced cartilage pathology. In Specific Aim 2, we will investigate the expression of HIF-2 in controlling cellular oxidative status by antioxidant regulation. By manipulating the expression HIF-2, using siRNA to silence HIF-2 gene expression and a hypoxia independent plasmid for overexpression, we will determine cellular oxidative status, ROS mediated activation of Ask1, chondrocyte catabolic activity and survival. By carefully analyzing the signaling mechanisms altered by oxidative stress in chondrocytes, our proposed studies will have an enormous impact on understanding molecular mechanisms of oxidative stress, and provide important information for developing novel targets for therapeutic intervention.
Public Health Relevance: This proposal will examine the relationship between environmental oxidants and antioxidant expression in cartilage cells; how this balance affects cartilage cell function and cartilage degeneration. Studies will include analysis of tissue and isolated cells from mice with impaired or improved antioxidant function and human osteoarthris tissue to determine these relationships. We will perform analyses to determine if genes that alter cartilage cell function are increased leading to the development of cartilage dysfunction.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1186/1755-1536-3-17
发表时间:
2010-09-01
期刊:
Fibrogenesis & tissue repair
影响因子:
--
作者:
[Freeman TA, Parvizi J, Dela Valle CJ, Steinbeck MJ]
通讯作者:
Steinbeck MJ
DOI:
10.1371/journal.pone.0185803
发表时间:
2017
期刊:
PloS one
影响因子:
3.7
作者:
[Zhang QS, Kurpad DS, Mahoney MG, Steinbeck MJ, Freeman TA]
通讯作者:
Freeman TA
DOI:
10.1038/cddis.2014.480
发表时间:
2014-11-13
期刊:
Cell death & disease
影响因子:
9
作者:
[]
通讯作者:
DOI:
10.1016/j.arth.2015.08.021
发表时间:
2016
期刊:
The Journal of arthroplasty
影响因子:
--
作者:
[M. Steinbeck;Peter Eisenhauer;M. Maltenfort;J. Parvizi;T. Freeman]
通讯作者:
M. Steinbeck;Peter Eisenhauer;M. Maltenfort;J. Parvizi;T. Freeman
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
-
批准号:8240982
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2011
-
负责人:Theresa A Freeman
-
依托单位:
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
-
批准号:8075299
-
项目类别:
-
资助金额:$35.94万
-
财政年份:2011
-
负责人:Theresa A Freeman
-
依托单位:
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
-
批准号:8604154
-
项目类别:
-
资助金额:$33.66万
-
财政年份:2011
-
负责人:Theresa A Freeman
-
依托单位:
Non-Thermal Plasma in Biomedicine: A New Paradigm for Redox Cell Activation
-
批准号:8432763
-
项目类别:
-
资助金额:$32.73万
-
财政年份:2011
-
负责人:Theresa A Freeman
-
依托单位:
ROS activation of Apoptosis Signal-regulated Kinase1 (Ask1) in chondrocytes
-
批准号:7872721
-
项目类别:
-
资助金额:$11.59万
-
财政年份:2010
-
负责人:Theresa A Freeman
-
依托单位:
海外基金